ライフサイエンスコーパス: enhanced survival

1 ither inhibitor alone (P < .001) and further enhanced survival.

2 se proximity of engrafted leukemic cells and enhanced survival.

3 tosis, activation of antitumor immunity, and enhanced survival.

4 g complex formation and caspase activity and enhanced survival.

5 ction led to decreased lung viral titers and enhanced survival.

6 ylated Pkn14 may explain why tan cells enjoy enhanced survival.

7 matologic parameters, splenic histology, and enhanced survival.

8 ry for the previously observed IL-7-mediated enhanced survival.

9 and functions of variant proteins related to enhanced survival.

10 ody irradiation improved HSC engraftment and enhanced survival.

11 impairment in other core clock genes exhibit enhanced survival.

12 dence of clinically significant CKD and with enhanced survival.

13 ed postoperative renal function and possibly enhanced survival.

14 f the alternative NF-kappaB pathway for BAFF-enhanced survival.

15 levels in DP thymocytes, resulting in their enhanced survival.

16 O(+) cells was significantly associated with enhanced survival.

17 esulted in smaller, less invasive tumors and enhanced survival.

18 ol size during peak inflammation rather than enhanced survival.

19 reased surface expression of FcepsilonRI and enhanced survival.

20 rate neutrophil recruitment, activation, and enhanced survival.

21 sozyme conferred resistance to infection and enhanced survival.

22 ecreased alveolar-capillary protein leak and enhanced survival.

23 esponse parameters that could translate into enhanced survival.

24 were reached that neither caused damage nor enhanced survival.

25 appeared to be attributable predominantly to enhanced survival.

26 ocytic and DC infiltration of the tumors and enhanced survival.

27 the overexpression of the transgene with the enhanced survival.

28 as measured by reduction in tumor growth and enhanced survival.

29 of Th2-biased mice experienced significantly enhanced survival.

30 ion reduced centrilobular liver necrosis and enhanced survival.

31 mice to IFN-gamma knockout mice resulted in enhanced survival.

32 ioether linked vaccine construct resulted in enhanced survival.

33 mma2) as adults exhibit reduced symptoms and enhanced survival.

34 d significantly better growth inhibition and enhanced survival.

35 temia, decreased endothelial activation, and enhanced survival.

36 ectively enriched after chemotherapy through enhanced survival.

37 tasis, regression of established tumours and enhanced survival.

38 esulting in diminished pulmonary disease and enhanced survival.

39 lasting population of licensed NK cells with enhanced survival.

40 se to B cell receptor (BCR) crosslinking and enhanced survival.

41 GFP dramatically suppressed tumor growth and enhanced survival.

42 into normal or RAG1-deficient mice displayed enhanced survival.

43 nd decreased proliferation, whereas SPRY4 KD enhanced survival.

44 pe, reduced tumor burden and metastasis, and enhanced survival.

45 engineered to overexpress MYD88 L265P showed enhanced survival.

46 th 100 microg DNA encoding IFN-alpha1 showed enhanced survival (10/15) in comparison to mice treated

47 and in vivo, which results in substantially enhanced survival (180-260%) when the prodrug ganciclovi

48 Overweight and obesity are associated with enhanced survival after a CRC diagnosis.

49 Furthermore, ORAI1-deficient T cells showed enhanced survival after adoptive transfer into immunocom

50 edium, increased cellular proliferation, and enhanced survival after detachment from the culture subs

51 LB/c or C57BL/6 mouse strain showed markedly enhanced survival after infection compared to adult mice

52 re, rapid cell-cycle checkpoint recovery and enhanced survival after irradiation, whereas functional

53 eously treated with IL-12 at birth displayed enhanced survival after lethal challenge with infectious

54 bited decreased weight loss and dramatically enhanced survival after lethal challenge with infectious

55 Effective relapse therapy enhanced survival after progression, translating into a

56 mismatched allogeneic marrow grafts and show enhanced survival after such transplants.

57 gene resulted in diminished liver injury and enhanced survival after treatment in vivo with TNF-alpha

58 BT549(gal-3 wt) also exhibited enhanced survival against peroxynitrite (up to 400 micro

59 asmodium berghei ANKA erythrocytes exhibited enhanced survival and a diminished blood-brain barrier d

60 thermore, B7x(-/-) mice showed significantly enhanced survival and a memory response to tumor rechall

61 on of a contactin ligand expressed on axons, enhanced survival and additionally promoted myelination

62 ne-phosphorylates endothelial Tie-2, causing enhanced survival and cell-cell stabilization.

63 roapoptotic BH3-only protein, which leads to enhanced survival and chemoresistance of human lung canc

64 Results demonstrated significantly enhanced survival and decreased tumor burden in mice pre

65 er recruitment of CD4 cells, consistent with enhanced survival and differences in recruitment and Th1

66 n of impaired remyelination mediated through enhanced survival and differentiation of OPs in the spin

67 irus replication and at the site of disease, enhanced survival and diminished morbidity in rJ2.2-infe

68 Finally, CD70 reverse signaling enhanced survival and effector function of human NK cell

69 model of lupus, in which the pathologically enhanced survival and expansion of germinal center B cel

70 Inhibition of activins significantly enhanced survival and expansion of pancreatic epithelial

71 (+) T cells to induce GVHD resulted from the enhanced survival and expansion of those cells.

72 bPTEN/SHIP(-/-) B cells exhibit enhanced survival and express more MCL1 and less Bim.

73 -10 (IL-10) modulates EPC biology leading to enhanced survival and function after transplantation in

74 t precancerous B cells have already acquired enhanced survival and growth capabilities before transfo

75 middle-income countries are associated with enhanced survival and improved cognitive development, bu

76 4(+) or CD25(+) cells before therapy further enhanced survival and in vivo CTL activity.

77 h of CD34(+) cells, which was accompanied by enhanced survival and increased cell cycle traverse in c

78 apoptosis of neutrophils, resulting in their enhanced survival and increased phagocytic function.

79 timulated in the presence of TGF-beta showed enhanced survival and increased production of interleuki

80 ted follicles encapsulated within fibrin had enhanced survival and integration with the host tissue f

81 noparticles (MSNPs); this uptake resulted in enhanced survival and markedly reduced metastasis.

82 Furthermore, PEDF intracerebral infusion enhanced survival and maturation of newly born oligodend

83 CQ significantly enhanced survival and may augment current treatment and

84 phosphatidylinositol-3 kinase (PI3K)/Akt and enhanced survival and migration.

85 Both enhanced survival and motility are critical to metastasi

86 The end-result is enhanced survival and neuritogenesis of various types of

87 n observed in R6/2 mice, suggesting that the enhanced survival and neuroprotection might be attributa

88 h the hydrogels optimized in vitro exhibited enhanced survival and oligodendrogenic differentiation a

89 determination of risk and guide therapies to enhanced survival and patient well-being.

90 hat CSF-1/c-fms signaling may be involved in enhanced survival and possibly invasion by cervical canc

91 feration of endometrial epithelial cells and enhanced survival and proliferation of human stromal cel

92 tial therapeutic target in AML to reduce the enhanced survival and proliferation of leukemic cells, w

93 n of Wnt signaling in the transplanted HSPCs enhanced survival and proliferation of Muller-HSPC hybri

94 5, significantly expands mature NK cells via enhanced survival and proliferation.

95 liver transplants, bucillamine significantly enhanced survival and protected against hepatic injury.

96 e mouse model of sepsis led to significantly enhanced survival and reduced bacterial load in several

97 nt C57BL/6-scid and BALB/cByJ-scid mice also enhanced survival and reduced parasitemia, indicating th

98 tro-generated T cells to SCID or BALB/c mice enhanced survival and reduced virus titers in the lung.

99 hat the TrkB-BDNF pathway is associated with enhanced survival and resistance to chemotherapy in neur

100 ection, and persist through a combination of enhanced survival and slow homeostatic turnover.

101 ortion of CLL are dependent on NF-kappaB for enhanced survival and suggest that inhibition of NF-kapp

102 cine/Fc-OX40L therapy is capable of inducing enhanced survival and tumor elimination in the GL261 mou

103 rophil responses, resulting in variants with enhanced survival and virulence.

104 further activation of the FLT3 receptors and enhanced survival and/or decreased apoptosis in leukemia

105 tor independent survival, artemin once again enhanced survival, and by P20 it promoted survival as ef

106 enotypes, including increased proliferation, enhanced survival, and increased anchorage-independent g

107 greater activation of the PI3K/Akt pathway, enhanced survival, and increased apoptosis in response t

108 ly reduced both tumor growth and metastasis, enhanced survival, and promoted regression of both tumor

109 The enhanced survival, and thus clonal expansion, supported

110 ng in significantly reduced tumor growth and enhanced survival as compared to a Dexo vaccine formulat

111 ich gave rise to improved body condition and enhanced survival as hosts aged.

112 afts from normal donors showed significantly enhanced survival at all graft sites compared with conju

113 A cooperating mutation that enhanced survival (BCL2) was not sufficient to complete

114 CBLB502 injected after irradiation also enhanced survival, but at lower radiation doses.

115 ion and release of GM-CSF is responsible for enhanced survival, but the mechanisms controlling cytoki

116 induced by 4-1BB that was associated with an enhanced survival capability of CD8(+) post-REP TIL when

117 ells (e.g., anchorage-independent growth and enhanced survival capability) and that this effect requi

118 of plasma cells, presumably reflecting their enhanced survival capacity in vivo.

119 expression differences may contribute to the enhanced survival capacity of the El Tor biotype in envi

120 n of survivin, cyclin D1 and FAK, leading to enhanced survival, cell-matrix adhesion and proliferatio

121 translocating protein, showed significantly enhanced survival compared to controls.

122 p69 demonstrated significantly enhanced survival compared to that of the vector control

123 ti-cancer plasmid DNA provided significantly enhanced survival compared to the same plasmid DNA loade

124 ductance, higher relative water content, and enhanced survival compared to wild-type controls.

125 fected Bax(-/-) mice had delayed disease and enhanced survival compared to WT mice.

126 ) cells, and ATP-treated T(H)17 cells showed enhanced survival compared with ATP-treated T(H)1 cells,

127 (-/-) mice (B-Traf3(-/-)) display remarkably enhanced survival compared with littermate control (WT)

128 IP-10-neutralizing mAbs showed significantly enhanced survival compared with mice treated with contro

129 inflamed cerebrospinal fluid (CSF) exhibited enhanced survival compared with neutrophils isolated fro

130 nly one of numerous CXCR2 ligands, exhibited enhanced survival compared with that of WT mice followin

131 (G12V) PDCs expressing mutant p53(V143A) had enhanced survival compared with WT PDCs transduced with

132 itabine (3 weekly, 6-mg doses) significantly enhanced survival, compared with PT-RAIT alone.

133 of neural stem cells in vitro; however, the enhanced survival correlates with increased genetic dama

134 Enhanced survival did not correlate with numbers of BAp:

135 In UT7epo cells, siRNA knock-down of DAPK2 enhanced survival due to cytokine withdrawal, and DAPK2'

136 s greatly upregulated in thymocytes that had enhanced survival due to transgenic expression of a stab

137 rast, knock-down of Hdac1 in APL mice led to enhanced survival duration of the leukemic animals.

138 itionally, neutrophils from hPR3Tg displayed enhanced survival during apoptosis compared with control

139 6 M and 10-9 M) for increased growth and for enhanced survival during incubation at nonpermissive tem

140 In WBB6F(1)-Kit(W-sh/W-sh) mice, mast cells enhanced survival during moderately severe CLP but did n

141 of the endotoxin lipopolysaccharide and show enhanced survival during subsequent mechanical ventilati

142 model) for up to 46 days, but significantly enhanced survival during sudden anaerobiosis.

143 resistance to ionizing radiation and exhibit enhanced survival following 8-10 Gy total body irradiati

144 ar transduction with Ad:IFN-beta resulted in enhanced survival following infection with HSV-1.

145 13-deficient mice demonstrated significantly enhanced survival following infection, which correlated

146 Strikingly, Il21r(-/-) mice had enhanced survival following PVM infection, and moreover,

147 administration of exogenous IFN-gamma alone enhanced survival from H5N1 influenza virus infection, a

148 days (P < 0.0001) and delivery in icodextrin-enhanced survival further.

149 imals carrying orthotopic tumors, and HDACIs enhanced survival further.

150 o increased resistance to apoptotic stimuli, enhanced survival, growth advantage, and differentiation

151 with bioluminescent reporter cells provided enhanced survival, higher local retention, and extended

152 These observations coincide with enhanced survival, improved strength and decreased motor

153 IL-13 enhanced survival in 100% O(2).

154 bition of IGF2 mRNA accumulation may lead to enhanced survival in a model of HCC.

155 c JNK1/2 deletion led to tumor reduction and enhanced survival in Akt/Notch- or p53/Kras-induced ICC

156 kemic cells from Mer(high) xenografts showed enhanced survival in coculture.

157 glucosylated form of the O-antigen mediated enhanced survival in human serum and decreased complemen

158 ltafepA), inhibits MPO activity and exhibits enhanced survival in inflamed guts.

159 er therapy and induced tumor regression that enhanced survival in mice with pulmonary metastases.

160 tumor site and induced tumor regression that enhanced survival in mice with pulmonary tumors.

161 ant hepatic failure, leading to dramatically enhanced survival in mice.

162 These gene signatures were associated with enhanced survival in patients with proneural GBM.

163 were highly coexpressed and associated with enhanced survival in stage III patients; however, CXCR3

164 17 was identified as an essential factor for enhanced survival in the absence of CB2, because CCL17 x

165 BL mutants in the TF-1 cell line resulted in enhanced survival in the absence of GM-CSF.

166 s resulted in increased expression of CXCR4, enhanced survival in the absence of growth factors, and

167 ent of immunoglobulin G1 results in markedly enhanced survival in the circulation (t1/2 > 7 days), co

168 ve stress and thereby mediate quiescence and enhanced survival in the HSC compartment, a function tha

169 , this mutant strain exhibited significantly enhanced survival in the intracellular compartments of m

170 onses to the larvae indicated that there was enhanced survival in the KO animals and decreased surviv

171 (k2)ABCDE genes restored capsule expression, enhanced survival in the murine urinary tract, and resto

172 paraquat, and H(2)O(2) showed significantly enhanced survival in the presence of (3R,5S,7as)-(3,5-bi

173 or treated passively with mAb 20B1 exhibited enhanced survival in the sepsis model, whereas decrease

174 ed pancreatic islets may contribute to their enhanced survival in the transplant setting.

175 dition, therapeutic administration of FGF-20 enhanced survival in this model.

176 mice exhibited reduced turnover in vivo and enhanced survival in vitro, indicative of lymphoaccumula

177 Treg was induction of Bcl-x(L) resulting in enhanced survival in vitro.

178 macrophages isolated from BCL-6-/- mice show enhanced survival in vitro.

179 daptive immune response was not required for enhanced survival, it was necessary for STAg-mediated vi

180 onstrate that 8 of the 12 isolates exhibited enhanced survival levels in 1.5 mM ASN compared to level

181 2 days after H5N1 influenza virus infection enhanced survival, lowered viral titers, and reduced cli

182 Enhanced survival mediated by either poly(I:C) or CpG DN

183 ization, suppressed tumor vessel growth, and enhanced survival (metastasis model).

184 IGF-1 enhanced survival, migration, and growth of cells from b

185 ls in the oligodendrocyte lineage, including enhanced survival, mitosis, migration, and differentiati

186 a albicans, with resistance characterized by enhanced survival, more rapid fungal clearance in key pe

187 ubdominant TCD8 clonal size was due to their enhanced survival, not proliferation.

188 eutralizing anti-IL-17R antibody ablated the enhanced survival observed in IL-10(-/-) mice.

189 The enhanced survival observed in the infected EP3(-/-) mice

190 ne limits fly survival, thus confirming that enhanced survival observed in these flies is related to

191 and SLPC both express CD28, but CD28-driven enhanced survival occurred only in the LLPC.

192 ion of the PTEN lipid phosphatase results in enhanced survival of a diversity of tumors.

193 Moreover, we found that STAT3 enhanced survival of activated T-cells by up-regulating

194 neal delivery of Ad-TD-nsIL-12 significantly enhanced survival of animals with orthotopic PaCa and cu

195 Enhanced survival of autoreactive B cells, due to the pr

196 Racemase-dependent production of D-alanine enhanced survival of B. anthracis during interaction wit

197 The enhanced survival of BALEos was 75% inhibited at 6 days

198 Notably, cannibalism of MSCs enhanced survival of BCCs deprived of nutrients but supp

199 Enhanced survival of Bcl-xL transgenic neutrophils incre

200 CEP1347 also enhanced survival of both rat and human neurons and inhi

201 Creatine supplementation significantly enhanced survival of C2C12 cells incubated under hyperto

202 Additionally, it was found that enhanced survival of CD4 T cells was equally dependent o

203 Enhanced survival of CD4(-/-) T cells was due to decreas

204 d infection in the brain and spinal cord and enhanced survival of CD8-deficient mice.

205 protein kinase activity had no effect on the enhanced survival of cells expressing Akt.

206 Rather, inhibition of autophagy enhanced survival of cells with moderate Bcl-2 expressio

207 acetam, an FDA-approved anti-epileptic drug, enhanced survival of chemotherapy drug-treated neurons,

208 ys by E(2) leads to pulmonary metastasis via enhanced survival of detached tuberin-null cells.

209 The enhanced survival of enkephalinergic striatal neurons wa

210 nd host signaling pathways contribute to the enhanced survival of EPEC-infected host cells.

211 Thus, through enhanced survival of existing regulatory T cells, and th

212 infected Tax-expressing cells contributed to enhanced survival of exosome-recipient cells when treate

213 Melatonin significantly enhanced survival of glial cells (as revealed by glial c

214 Constitutive expression of v-Akt likewise enhanced survival of H(2)O(2)-treated NIH3T3 cells.

215 s also effective therapeutically, conferring enhanced survival of H5N1 virus-challenged mice when tre

216 injection of sRAGE and hBD-MSCs resulted in enhanced survival of hBD-MSCs and angiogenesis in PIRI-C

217 eased nuclear p16 expression correlates with enhanced survival of head and neck cancer patients (p <

218 ockade of c-Met during T cell priming led to enhanced survival of heart, but not skin, allografts ass

219 The enhanced survival of hearts from MHC class I- and class

220 GABA(A) receptor activity for 5-8 d in vitro enhanced survival of hippocampal neurons, suggesting tha

221 I knockout donor tissue led to significantly enhanced survival of HR but not LR allografts.

222 The enhanced survival of infected enterocytes by molecules s

223 eficient for Wwox also exhibit significantly enhanced survival of ionizing radiation and bleomycin tr

224 aks (DSBs) induced by ionizing radiation and enhanced survival of irradiated cells.

225 ructs expressing antisense mRNA, resulted in enhanced survival of KIM-2 cells.

226 anscription of host cell genes important for enhanced survival of latently infected cells.

227 These advantages translate to significantly enhanced survival of LbL-probiotics in vivo.

228 pretreated with treprostinil and forskolin, enhanced survival of lethally irradiated recipient mice.

229 is 42-kDa protein directly correlated to the enhanced survival of M. smegmatis p69 in U-937 cells.

230 (p75) function appears to be associated with enhanced survival of major histocompatibility complex-di

231 ells in secondary transplant recipients, and enhanced survival of mice after discontinuation of treat

232 Administration of truncated KC significantly enhanced survival of mice lethally infected with C. albi

233 Hu-1.6/1.1 also enhanced survival of mice that developed fatal sepsis af

234 In the presence of RIG-I, the LR miRNAs enhanced survival of mouse neuroblastoma cells, which co

235 Antiviral treatment with oseltamivir enhanced survival of obese mice.

236 Immunosuppression enhanced survival of OECs and FBs, but only OEC transpla

237 d loss in ERK and Akt activation by H2O2 and enhanced survival of old hepatocytes to levels similar t

238 godendrocytes and their progenitor cells, no enhanced survival of oligodendrocytes or progenitors was

239 wed an evident reduction in astrogliosis and enhanced survival of oligodendrocytes.

240 st in the absence of a mechanism for odorant-enhanced survival of OSNs.

241 ssociation between carbapenem resistance and enhanced survival of P. aeruginosa in infected murine ho

242 We found that a single injection enhanced survival of photoreceptors and improved retinal

243 e investigated whether Survivin mediates the enhanced survival of primary hematopoietic progenitor ce

244 transcriptional regulation and significantly enhanced survival of prostate cancer cell lines ABAC3 an

245 morpholino suppression of CD47 dramatically enhanced survival of random tissue flaps.

246 Enhanced survival of recipient mice was causally related

247 LEDGF enhanced survival of retinal photoreceptor cells under s

248 , memantine treatment was associated with an enhanced survival of RGCs in the inferior retina.

249 not an adverse toxic effect was indicated by enhanced survival of ribosome mutants after arsenic expo

250 LEDGF enhanced survival of RPE cells in culture when challenge

251 lay of disease onset, expansion of lifespan, enhanced survival of spinal motor neurons, and maintenan

252 TGF-beta1 also enhanced survival of TCR-stimulated CD4+CD44high T cells

253 L) expression, leading also to significantly enhanced survival of terminally differentiating erythroi

254 anism to modify bound targets and facilitate enhanced survival of the bacterium.

255 d tonic-clonic convulsions and significantly enhanced survival of the mutant mice.

256 A trend for enhanced survival of the vaccinated macaques was also ob

257 ly attenuated by MV-alpha CD38, resulting in enhanced survival of these mice compared with the contro

258 IP therapy enhanced survival of those with gross residual disease.

259 ose deprivation substantially attenuated the enhanced survival of TRAF3-deficient B cells, with a dec

260 ogenicity of TS(-) cells by anti-FasL and in enhanced survival of TS(-) clones selected for resistanc

261 -expressing effector cells that mediated the enhanced survival of tumor-bearing mice by MOv18 IgE and

262 fected females from three fly strains showed enhanced survival or fecundity associated with Wolbachia

263 p38 MAPK inhibitor (SB239063) significantly enhanced survival over an 18-week period compared with t

264 e phase of the fluctuations was initiated by enhanced survival, particularly of juveniles and fecundi

265 als by malignant cells, imbuing them with an enhanced survival phenotype.

266 formly expressing markers associated with an enhanced survival potential.

267 e-specific CD8(+) T cell response and showed enhanced survival rate and lower viral burden in the bra

268 These slow clearance rates associate with enhanced survival rates of ring-stage parasites briefly

269 thologs of these genes in flies dramatically enhanced survival rates under hypoxia, demonstrating tha

270 ities in response to polyclonal stimulation, enhanced survival rates with elevated expression of Bcl-

271 efficiently limited infection in the CNS and enhanced survival rates.

272 Remarkably, Atg16L1(HM) mice display enhanced survival rather than susceptibility upon infect

273 n by these cells did not contribute to their enhanced survival; rather, ROS promoted their growth fac

274 -MIBG resulted in decreased tumor growth and enhanced survival relative to injection of either agent

275 ver, INR beta-Myc-expressing cells exhibited enhanced survival relative to parental and betaDelta cel

276 Marek's disease in chickens and resulted in enhanced survival relative to two independently produced

277 a balance of both reduced proliferation and enhanced survival, the latter being proportionally great

278 hat overexpression of ng1686 does not confer enhanced survival to hydrogen peroxide on gonococci.

279 Enhanced survival to weaning appeared to be accomplished

280 leads to decreased caspase 3/7 activity and enhanced survival under conditions of ischemic stress.

281 channel closure, glycerol accumulation, and enhanced survival under hyperosmotic stress.

282 ree mice resulted in bacterial clearance and enhanced survival upon infection.

283 e burdens (P < 0.01), and displayed markedly enhanced survival versus the wild type (WT) when treated

284 revascularization and female sex, such that enhanced survival was associated with ESVi.

285 By using mice transgenic for human CD16A, enhanced survival was observed due to expression of CD16

286 Greatly enhanced survival was observed when mice immunized with

287 To demonstrate that enhanced survival was promoted by donor-specific Th2 cel

288 Enhanced survival was statistically significant after 5

289 rating mutations that deregulated growth and enhanced survival were associated with normal karyotypes

290 to hypoxia-reoxygenation insult in vitro and enhanced survival when grafted into the heart.

291 uercus stellata had overall reduced RGR, but enhanced survival when grown with grass, while survival

292 Deficiency of ROCK1 also results in enhanced survival, whereas wild-type mice die rapidly in

293 f supernatants from polarized hES-RPE showed enhanced survival, which was ablated by the presence of

294 The enhanced survival with anti-CD32 mAb was inhibited by an

295 ese variables did not identify patients with enhanced survival with ICD implantation.

296 risk assessment and identifies patients with enhanced survival with ICD in a patient cohort with redu

297 +) /SCLtTA/TRE-BCR-ABL mice, the combination enhanced survival with reduced leukaemia development in

298 serovar Typhimurium strains all demonstrated enhanced survival within J774A.1 cells and murine perito

299 bacterial inoculum, cylE also contributed to enhanced survival within phagocytes that was attributed

300 ore-matched patients provides diabetics with enhanced survival without any increase in perioperative